Innovis Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$310K Buy
37,049
+16,607
+81% +$139K 0.12% 103
2023
Q2
$508K Buy
+20,442
New +$508K 0.19% 71